CNBC Covers Sema4’s Plans to Become a Publicly Traded Company

CNBC featured Sema4 on its Fast Money Halftime Report show on February 10th, 2021. They interviewed Sema4 Founder and CEO Eric Schadt, and Eli Casdin and Keith Meister of CM Life Sciences (NASDAQ: CMLF), about the two companies entering into a definitive business combination agreement. Among other things, Eric, Eli, and Keith covered Sema4’s value proposition and opportunity to accelerate its growth, and why Sema4 and CM Life Sciences are combining.

For more information, please read the press release here.